Get 20% lifetime commission for referring investors to digrin.com
here.
Alterity Therapeutics Limited ( PRNAF) - Key Metrics
Stock symbol PRNAF is outdated, potentially delisted? Maybe it is available on other exchange?
PRNAF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | $0 | $0 | ? |
| 2025Q4 | $0 | $0 | $0 | $0 |
| 2025Q2 | $0 | $0 | $0 | $0 |
| 2024Q4 | $0 | $0 | $0 | $0 |
| 2024Q2 | $0 | $0 | $0 | $0 |
PRNAF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | -2.12 |
| 2025Q4 | ? | -3.76 |
| 2025Q2 | ? | -1.43 |
| 2024Q4 | ? | -0.63 |
| 2024Q2 | ? | -0.67 |
PRNAF
Price: $0.06
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -1.01
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.0 million